Herceptin study gives fresh hope to breast cancer sufferers

Women with early breast cancer who are treated with the drug Herceptin have almost a 50% reduced risk of the disease returning, according to research published today.

Campaigners hope the study, in the New England Journal of Medicine, will help speed up access to the drug which has so far been limited.